Article Details

Bioxyne granted Australia's first GMP licence for Psilocybin and MDMA manufacturing

Retrieved on: 2024-02-05 01:05:45

Tags for this article:

Click the tags to see associated articles and topics

Bioxyne granted Australia's first GMP licence for Psilocybin and MDMA manufacturing. View article details on hiswai:

Excerpt

Bioxyne's entry into medical cannabis manufacturing, initiated in 2022, has seen rapid progress, establishing a robust brand and distribution network ...

Article found on: www.australianmanufacturing.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo